Alur Orthopedic Implants
Alur Orthopedic Implants
The global orthopedic market is witnessing a significant shift toward Revision Hip and Knee Arthroplasty. As primary joint replacements become more common among younger, more active populations, the subsequent need for secondary (revision) surgeries is rising exponentially. Today, hospitals and surgical centers worldwide are looking for more than just a replacement; they are seeking Comprehensive Revision Systems that can address complex bone loss, infection, and mechanical failure.
Current industrial data suggests that the revision market is growing at a CAGR of over 5.5% globally. This is driven by an aging demographic in developed nations and an increasing middle-class access to healthcare in emerging economies. As a leading Revision Hip/Knee Systems Manufacturer, we understand that these surgeries are significantly more complex than primary procedures, requiring specialized instruments and versatile implant designs.
Revision surgeries often involve dealing with compromised bone stock. Our systems utilize porous titanium coatings and modular components that allow surgeons to customize the fit to the patient's unique anatomy. From long-stem femoral components to augments and cages, our industrial manufacturing focus is on biological fixation and long-term stability.
Our flagship S-ROM Titanium Alloy Cementless Hip Joints represent the pinnacle of revision technology. By utilizing medical-grade titanium alloy, we ensure maximum biocompatibility and reduced risk of stress shielding. This system is specifically designed for revision cases where femoral bone loss is present, offering a modular sleeve and stem design that provides distal and proximal stability independently.
As a specialized manufacturer, our factory implements high-precision CNC machining and vacuum plasma spraying to create surfaces that encourage rapid osseointegration, ensuring that the revision surgery lasts as long as—or longer than—the primary implant.
The move toward patient-specific implants is the biggest trend. 3D printing allows for complex geometries that match bone voids perfectly.
Integration with surgical navigation and robotic systems to improve the accuracy of component placement in difficult revision scenarios.
Development of antibiotic-loaded or bio-active coatings to combat periprosthetic joint infection (PJI), a leading cause of revision failure.
Global medical distributors and hospital groups are increasingly looking for reliable supply chain partners in China. The demand is not just for the implants themselves, but for a holistic "System" that includes:
Our company satisfies these needs by providing over 8,000 product specifications, ensuring that every surgical scenario, from pediatric orthopedics to geriatric trauma, is covered with precision-engineered equipment.
For complex revision TKA (Total Knee Arthroplasty), our HRSK Hinged Rotating System offers a mechanical solution for knees with severe ligamentous instability or massive bone loss. This system provides the necessary constraint while allowing for natural kinematics via a rotating platform.
As exporters, we ensure these high-end systems are packaged in sterilized, hospital-ready kits, reducing the logistical burden on international healthcare providers. Our R&D focuses on making the "hinge" more durable, using advanced polyethylenes and cobalt-chrome alloys to minimize wear debris.
The company places great importance on scientific and technological innovation, as well as new product research and development. Its product development strategy follows the principles of "blue ocean, differentiation, and focus strategy," with a strong emphasis on limb orthopedics, pediatric orthopedics, and internal and external fixation products for foot and ankle surgery.
With a production capacity covering more than 8,000 product specifications in orthopedic trauma, spinal implants, and surgical instruments, the company has gradually established competitive advantages in research and development, production and manufacturing, quality control, marketing, and other key areas.
Year Founded
Exp. Countries
Top-tier Hospitals
IP Rights/Patents
Global Agents
The marketing team consists of more than 40 professionals, with sales and technical service personnel present in over 20 major cities. The company has built a nationwide marketing network covering 31 provinces and cities, collaborating with more than 300 agents and serving over 300 top-tier teaching hospitals. We actively engage in academic promotion, technical services, and product training, participating in more than 50 academic conferences annually.
Our self-operated export business is rapidly expanding, with successful implementations in Brazil, Colombia, Peru, Egypt, and Morocco. We are not just a supplier; we are an innovation partner dedicated to improving patient outcomes globally.
